Keyphrases
Therapeutic Target
100%
Interferon Regulatory Factor 4 (IRF4)
100%
Adult T-cell Leukemia
100%
Antisense Oligonucleotides
33%
Lenalidomide
33%
Malignancy
22%
Lymphoma Cells
22%
Somatic mutation
11%
Nuclear factor-B
11%
Chemotherapy Resistance
11%
T Cell Receptor
11%
Host Gene
11%
CD4+ T
11%
Ethyl
11%
Median Survival
11%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
11%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
11%
Transcriptome Analysis
11%
Proliferation in Vitro
11%
Cell Expansion
11%
Soluble interleukin-2 Receptor (sIL-2R)
11%
Receptor Subunits
11%
Downstream Effectors
11%
Thymic Selection
11%
RNA Degradation
11%
Time-dependent Inhibition
11%
Viral Oncoproteins
11%
RNase H
11%
High Mobility Group Proteins
11%
In Situ Transcriptomics
11%
Medicine and Dentistry
Adult T-Cell Leukemia/Lymphoma
100%
Interferon Regulatory Factor 4
100%
Lenalidomide
33%
Antisense Oligonucleotide
33%
Biological Marker
22%
Cancer
22%
Lymphoma Cell Line
22%
Somatic Mutation
11%
Gene Expression Profiling
11%
In Vitro
11%
T-Helper Cell
11%
Nuclear Factor
11%
Alternative Complement Pathway C3 C5 Convertase
11%
Cell Expansion
11%
Cell Line
11%
Cytotoxic T-Cell
11%
T Lymphocyte Receptor
11%
Human T-Lymphotropic Virus 1
11%
Oncoprotein
11%
Thymocyte
11%
Receptor Subunit
11%
Ribonuclease
11%
Interleukin 2 Receptor
11%
RNA Degradation
11%
High Mobility Group Protein
11%
Immunology and Microbiology
T Cell
100%
Interferon Regulatory Factor 4
100%
Antisense
33%
Lenalidomide
33%
Lymphoma Cell Line
22%
T-Helper Cell
11%
Complement Factor B
11%
Cell Expansion
11%
Cell Line
11%
T Cell Receptor
11%
Thymocyte
11%
Cytotoxic T Cell
11%
Human T-Lymphotropic Virus 1
11%
RNA Degradation
11%
Interleukin 2 Receptor
11%
Somatic Mutation
11%
Time-Dependent Inhibition
11%
Gene Expression Assay
11%
Pharmacology, Toxicology and Pharmaceutical Science
T Cell Leukemia
100%
Interferon Regulatory Factor 4
100%
Lenalidomide
33%
Antisense Oligonucleotide
33%
Biological Marker
22%
Alternative Complement Pathway C3 C5 Convertase
11%
Nuclear Factor
11%
Chemotherapy
11%
T Lymphocyte Receptor
11%
Oncoprotein
11%
Ribonuclease
11%
Receptor Subunit
11%
Human T-Lymphotropic Virus 1
11%
High Mobility Group Protein
11%
Interleukin 2 Receptor
11%